Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients

MR Rafati, MR Rouini, M Mojtahedzadeh… - International journal of …, 2006 - Elsevier
Since the bactericidal effects of β-lactam antibiotics are time dependent, the optimum
strategy for their administration could be continuous infusion. In this prospective …

Comparison of the pharmacokinetics of piperacillin and sulbactam during intermittent and continuous intravenous infusion

J Langgartner, N Lehn, T Glück, H Herzig, F Kees - Chemotherapy, 2007 - karger.com
Background: The antibacterial effect of piperacillin/sulbactam depends on the time of drug
concentration above the minimal inhibitory concentration (MIC). Therefore, continuous …

Clinical outcomes of extended versus intermittent infusion of piperacillin/tazobactam in critically ill patients: a prospective clinical trial

SY Fan, HP Shum, WY Cheng, YH Chan… - … : The Journal of …, 2017 - Wiley Online Library
Study Objective To determine whether critically ill patients receiving extended‐infusion (EI)
piperacillin/tazobactam would have improved clinical outcomes compared with patients …

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis

JA Roberts, CMJ Kirkpatrick, MS Roberts… - International journal of …, 2010 - Elsevier
The objectives of this study were (i) to compare the plasma concentration–time profiles for
first-dose and steady-state piperacillin administered by intermittent or continuous dosing to …

Daily serum piperacillin monitoring is advisable in critically ill patients

N Blondiaux, F Wallet, R Favory, T Onimus… - International journal of …, 2010 - Elsevier
The aim of the present study was to evaluate the benefit of monitoring serum piperacillin
concentrations in critically ill patients. This was an 11-month, prospective, observational …

Continuous infusion of piperacillin/tazobactam in septic critically ill patients—a multicenter propensity matched analysis

J Gonçalves-Pereira, BS Oliveira, S Janeiro, J Estilita… - PLoS …, 2012 - journals.plos.org
The clinical efficacy of continuous infusion of piperacillin/tazobactam in critically ill patients
with microbiologically documented infections is currently unknown. We conducted a …

Prolonged vs intermittent infusion of piperacillin/tazobactam in critically ill patients: a narrative and systematic review

E Yusuf, H Spapen, D Piérard - Journal of critical care, 2014 - Elsevier
Purpose The purpose of this study is to review the rationale of prolonged (ie, extended or
continuous) infusion of piperacillin/tazobactam (PIP/TAZ) in critically ill patients and to …

Does consistent piperacillin dosing result in consistent therapeutic concentrations in critically ill patients? A longitudinal study over an entire antibiotic course

M Carlier, S Carrette, V Stove, AG Verstraete… - International journal of …, 2014 - Elsevier
Piperacillin plasma concentrations are known to vary between critically ill patients. However,
there are no comprehensive data on the variability of antibiotic concentrations within the …

Comparing clinical outcomes of piperacillin-tazobactam administration and dosage strategies in critically ill adult patients: a systematic review and meta-analysis

S Fawaz, S Barton, S Nabhani-Gebara - BMC Infectious Diseases, 2020 - Springer
Background Recently, continuous administration of piperacillin-tazobactam has been
proposed as a valuable alternative to traditional intermittent administration especially in …

Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial

JM Dulhunty, JA Roberts, JS Davis… - Clinical infectious …, 2013 - academic.oup.com
Background. Beta-lactam antibiotics are a commonly used treatment for severe sepsis, with
intermittent bolus dosing standard therapy, despite a strong theoretical rationale for …